HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rana P Singh Selected Research
Rana P Singh Research Topics
Disease
94
Neoplasms (Cancer)
01/2024 - 03/2002
32
Prostatic Neoplasms (Prostate Cancer)
01/2023 - 06/2002
29
Carcinoma (Carcinomatosis)
01/2023 - 06/2002
22
Carcinogenesis
01/2024 - 08/2002
16
Body Weight (Weight, Body)
01/2024 - 01/2004
11
Breast Neoplasms (Breast Cancer)
11/2023 - 05/2004
9
Adenocarcinoma
01/2020 - 11/2003
9
Skin Neoplasms (Skin Cancer)
01/2018 - 03/2002
9
Colorectal Neoplasms (Colorectal Cancer)
05/2014 - 10/2006
8
Neoplasm Metastasis (Metastasis)
01/2024 - 06/2003
8
Lung Neoplasms (Lung Cancer)
12/2022 - 06/2006
7
Hypoxia (Hypoxemia)
09/2015 - 09/2006
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 05/2003
4
Papilloma (Papillomatosis)
01/2008 - 03/2002
3
Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2017
3
Inflammation (Inflammations)
08/2019 - 09/2005
3
Urinary Bladder Neoplasms (Bladder Cancer)
01/2008 - 12/2003
3
Sunburn
08/2005 - 08/2004
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2005 - 03/2002
2
Atherosclerosis
01/2024 - 01/2005
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2024 - 01/2021
2
Glioma (Gliomas)
01/2019 - 09/2003
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2018 - 06/2018
Drug/Important Bio-Agent (IBA)
52
Silybin (Lagosa)
IBA
09/2022 - 03/2002
17
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2013 - 09/2003
16
Proteins (Proteins, Gene)
FDA Link
01/2024 - 09/2003
10
Phytochemicals
IBA
06/2022 - 05/2002
9
Biomarkers (Surrogate Marker)
IBA
01/2022 - 09/2003
9
Proliferating Cell Nuclear Antigen (PCNA)
IBA
02/2014 - 03/2002
9
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
10/2012 - 06/2006
9
Grape Seed Extract
IBA
07/2011 - 11/2002
8
Flavonoids
IBA
08/2019 - 06/2002
8
Phytic Acid (Inositol Hexaphosphate)
IBA
02/2009 - 03/2003
8
Silymarin
IBA
12/2008 - 03/2002
7
Androgens
IBA
01/2023 - 11/2002
7
fisetin
IBA
12/2022 - 02/2012
6
Enzymes
IBA
08/2023 - 01/2005
6
Cyclin-Dependent Kinases (cdk Proteins)
IBA
08/2019 - 11/2003
6
NF-kappa B (NF-kB)
IBA
07/2010 - 09/2003
6
Carcinogens
IBA
12/2007 - 08/2002
5
Antineoplastic Agents (Antineoplastics)
IBA
01/2024 - 02/2005
5
Antioxidants
IBA
03/2018 - 06/2002
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2017 - 11/2002
5
Cyclins
IBA
01/2017 - 03/2003
5
flavanone
IBA
01/2015 - 12/2003
5
beta Catenin
IBA
07/2010 - 12/2009
5
Transcription Factors (Transcription Factor)
IBA
07/2008 - 09/2004
5
Caspases
IBA
11/2006 - 11/2002
5
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
05/2005 - 03/2002
4
Berberine
IBA
01/2024 - 02/2014
4
acacetin
IBA
01/2023 - 04/2005
4
Drinking Water
IBA
01/2018 - 12/2007
4
Cytokines
IBA
10/2012 - 07/2008
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2012 - 08/2002
4
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
10/2012 - 06/2006
4
Cyclin D1
IBA
01/2010 - 06/2006
4
Insulin-Like Growth Factor Binding Protein 3
IBA
12/2007 - 09/2003
3
Alkaloids
IBA
01/2024 - 02/2014
3
MicroRNAs (MicroRNA)
IBA
01/2024 - 01/2019
3
diallyl trisulfide
IBA
01/2024 - 06/2021
3
Cadherins (E-Cadherin)
IBA
08/2023 - 12/2008
3
Vimentin
IBA
08/2023 - 12/2008
3
DNA (Deoxyribonucleic Acid)
IBA
11/2020 - 01/2005
3
Arsenic
IBA
01/2018 - 06/2011
3
Cytochromes c (Cytochrome c)
IBA
01/2016 - 11/2002
3
Caspase 3 (Caspase-3)
IBA
02/2014 - 09/2004
3
Azoxymethane
IBA
09/2010 - 10/2008
3
Matrix Metalloproteinases (MMPs)
IBA
12/2008 - 09/2006
3
Survivin
IBA
01/2008 - 12/2003
3
Phosphotransferases (Kinase)
IBA
11/2006 - 09/2004
3
Insulin-Like Peptides
IBA
02/2004 - 06/2002
3
milk-thistle extract
IBA
12/2003 - 06/2002
2
oxidized low density lipoprotein
IBA
01/2024 - 08/2019
2
Ligands
IBA
11/2023 - 06/2006
2
Conditioned Culture Media
IBA
11/2023 - 10/2013
2
benzyl isothiocyanate
IBA
11/2023 - 01/2016
2
Xenobiotics
IBA
08/2023 - 09/2005
2
Trypan Blue
FDA Link
08/2023 - 05/2003
2
decursin
IBA
01/2023 - 02/2005
2
coumarin
IBA
01/2023 - 01/2009
2
Cyclin-Dependent Kinase Inhibitor p27
IBA
01/2023 - 02/2009
2
Cyclin-Dependent Kinase 4
IBA
01/2023 - 09/2004
2
ErbB Receptors (EGF Receptor)
IBA
09/2022 - 09/2003
2
RNA (Ribonucleic Acid)
IBA
06/2022 - 06/2021
2
Messenger RNA (mRNA)
IBA
05/2021 - 12/2003
2
Insulin (Novolin)
FDA Link
01/2021 - 09/2010
2
usnic acid
IBA
01/2020 - 01/2013
2
Resveratrol
IBA
01/2020 - 11/2005
2
Zinc
IBA
01/2019 - 01/2005
2
Gallic Acid
IBA
03/2018 - 07/2006
2
Anthracyclines
IBA
01/2017 - 12/2004
2
matrigel
IBA
10/2013 - 02/2004
2
Tyrosine (L-Tyrosine)
FDA Link
10/2013 - 11/2005
2
Urethane (Ethyl Carbamate)
IBA
02/2011 - 06/2006
2
Nestin
IBA
02/2011 - 01/2009
2
Glycogen Synthase (Synthase I)
IBA
09/2010 - 12/2009
Therapy/Procedure
20
Chemoprevention
01/2016 - 01/2004
13
Therapeutics
01/2024 - 08/2002
3
Drug Therapy (Chemotherapy)
01/2016 - 05/2004
3
Radiotherapy
12/2015 - 11/2011